Inde Navarrettes Obsession Role Spurs Indie Horror Market Buzz Prediction Markets Signal Rising Odds of Fed Rate Hike by Mid2027 Why Chasing High Returns May Undermine LongTerm Investment Success Iran Nuclear Talks Hit Roadblocks Raising Uncertainty for Global Oil Markets Wall Street Analysts Weigh in on Charles River Laboratories Mixed Sentiment Persists Amazon Taps Amwell CoFounder to Lead Health Division as Top Executive Departs HIG Q1 2026 Earnings EPS Misses Estimates by 10 Shares Decline BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Negative EPS Highlights Operational Strain as Bond Price Edges Higher HBANL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment Plains GP Holdings PAGP Q1 2026 Earnings Strong EPS Beat Drives Stock Higher VZ Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Operational Stability Avnet AVT Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Art Technology Acquisition Warrants ARTCW Rally 606 to 035 Testing Key Resistance Gladstone Commercial Preferred GOODO Holds Steady Near 2023 as Yield Attracts Investors Northann Corp NCL Edges Higher A MicroCap Stock Testing Key Resistance Logitech LOGI Surges 65 Testing Key Resistance as Trading Volume Picks Up ProFrac Holding Corp ACDC Edges Lower Amid Consolidation Pressures Ekso Bionics EKSO Climbs 129 as Stock Tests Key Resistance Level Bionano Genomics BNGO Slips 16 as Stock Tests Key Support Near 116 Devon Energy DVN Loses Ground as Bearish Pressure Tests Support Levels Lazard Inc LAZ Edges Higher Amid Consolidation Key Levels in Focus Arbe Robotics ARBE Slides as Shares Approach Key Support at 115 Teck Resources Surges Over 4 as Commodity Demand Strengthens Amazon Taps Amwell CoFounder as New Health Chief as Top Exec Departs PEW Q1 2026 Earnings NarrowerThanExpected Loss Fails to Boost Sentiment Vertex Inc VERX Rallies 2 as Stock Approaches Key Resistance Zone Haverty Furniture Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher ARL Q3 2024 Earnings Loss Per Share of 108 Amid No Revenue Disclosure Stock Declines Nearly 7 LOMA Q1 2026 Earnings Strong EPS of 3505 Despite Negative Stock Reaction Lantheus Q1 2026 Earnings Strong EPS Beat Driven by Radiopharmaceutical Momentum REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs ATAT Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat IT Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence